New Alzheimer's treatments discussed at Monaco conference
By Zak Jackson, MonacoViews Editorial
Dr Déborah Cohen of the Rainier III centre outlined two emerging Alzheimer's treatments at the Ludo Mémo conference held at the Médiathèque Caroline.
Two new treatments for Alzheimer's disease, though not yet available to patients, offered fresh grounds for optimism at the Ludo Mémo conference held on Tuesday 23 September at the Médiathèque Caroline. Dr Déborah Cohen, a geriatrician at the Centre Rainier-III, presented the current state of research to an audience gathered in Monaco to hear about progress against a condition that affects a growing number of the Principality's ageing residents.
Dr Cohen described the research landscape as unprecedented in scope, pointing to advances that could eventually change how the disease is managed locally. While neither treatment has reached patients yet, their development marks a shift from the limited options that have characterised Alzheimer's care for decades.
For Monaco, where the population skews notably older than many European neighbours, the pace of this research carries real weight. Centre Rainier-III, which specialises in geriatric care, is likely to be among the first local institutions to integrate any approved treatment once it clears regulatory hurdles, making events like Ludo Mémo a useful barometer for families and carers watching the field closely.